Guangzhou Pharmaceutical Group Co., Ltd. (abbreviated as Guangzhou Pharmaceutical Group) is one of the largest pharmaceutical industry conglomerates in China. In 2021, it became the world's first enterprise to enter the Fortune Global 500 with traditional Chinese medicine as its main business. Guangzhou Pharmaceutical Group ranks 18th on the Global Most Valuable Pharmaceutical Brand List released by the international authoritative brand evaluation agency BF Company, with the highest brand growth rate in the country; For many consecutive years, it has topped the list of Chinese traditional medicine enterprises and has been awarded honors such as "National Civilized Unit", "National May Day Labor Award", "National Patriotic and Military Support Model Unit", and "National Advanced Collective in Poverty Alleviation".

During the 14th Five Year Plan period, Guangzhou Pharmaceutical Group will seize the new opportunities of the new round of reform and opening up and the construction of the Guangdong Hong Kong Macao Greater Bay Area, implement the leadership of party building, and make every effort to build a world-class comprehensive pharmaceutical and health group with the flourishing development of the four major sectors of Greater South Medicine, Greater Health, Greater Commerce, and Greater Medical!